AMSTERDAM, Feb 7 (Reuters) - Dutch chemicals and drugs group Akzo Nobel (AKZO.AS: Quote, Profile, Research) took the first step towards breaking itself up on Tuesday, boosting its shares with a plan to list part of its pharmaceuticals unit separately this year.
